Chipiron is a French deeptech company developing a compact, lower-cost MRI system designed for use in smaller healthcare facilities, mobile units, and remote regions. The company miniaturises MRI technology into an ultra-low-field, mobile unit to broaden access beyond large hospitals and university medical centers. The $17M Series A will fund completion of development and the construction of its first clinical prototypes. Clinical trials are scheduled to begin in 2026. By 2028 Chipiron aims to have clinical prototypes, secure FDA and CE certifications, and deploy at least 100 commercial units, with a primary focus on the U.S. market. The product targets the global MRI market (estimated at ~$10B) and seeks to make MRI more affordable and flexible for broader patient care.

Total raised

$17M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2025